The Effect of a Stepped-care Metacognition-based Intervention on Managing Fear of Cancer Recurrence
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThe University of Hong Kong
About this trial
A sequential multiple-assignment randomized controlled trial (SMART) will be used to assess the effect of an adaptive stepped-care intervention on FCR in cancer survivors with subclinical levels of fear of cancer recurrence.
Eligibility criteria
Qualifiers
Cantonese- or Mandarin-speaking Chinese patients diagnosed with curable breast, colorectal, or gynecological cancer, who had completed treatment (except endocrine therapy) within five years, and with a Fear of Cancer Recurrence Inventory-Short Form (FCRI-SF) score of 13 to 21 indicating subclinical FCR will be included.
Disqualifiers
Patients with metastatic cancer, with a current diagnosis of depression or psychosis, or who are already receiving psychological treatment will be excluded.
Trial design
Treatments tested in this trial
- eConquerFear
- eHealthMaintenance
- ConquerFear
- eConquerFear+eHealthMaintenance
Treatment groups
300 Participants
are divided into 4 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov